22 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.
Sankyo
Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
University of Warwick
Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
Hokkaido University
Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.
TBA
Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
University of Paris
Bacterial transferase MraY inhibitors: synthesis and biological evaluation.
University of Paris
Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.
Hokkaido University
Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.
Tokyo University of Agriculture and Technology
Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
Cardiff University
Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.
University of Warwick
Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation.
Hokkaido University
Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.
Hokkaido University
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.
Sankyo
Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
Duke University
Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY.
Aventis Pharma
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
Griffith University
Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.
Academy of Sciences of The Czech Republic V.V.I.
Antibacterial Muraymycins from Mutant Strains of Streptomyces sp. NRRL 30471.
Nanjing University of Chinese Medicine
N-substituted indole derivatives as PGE2 receptor modulators
Idorsia Pharmaceuticals